Chronic Leukemias

Chronic Leukemias

Up next

Laryngeal Infections

Send us Fan MailNinja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob tackle laryngeal infections, a high-risk group of conditions where the key challenge is recognizing impending airway compromise rather than simply choosing an antibiotic. The episode is built arou ...  Show more

Deep Neck Infections

Send us Fan MailNinja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob discuss deep neck infections, one of the highest-stakes topics in ENT, where missed details can rapidly lead to airway compromise, vascular involvement, or mediastinal spread. The focus is on buil ...  Show more

Recommended Episodes

Precision Medicine in Chronic Lymphocytic Leukemia (CLL)
EHA Unplugged

Join us for a discussion with Prof Paolo Ghia, MD, PhD, from Università Vita Salute San Raffaele, Milan (Italy), as he explores how precision medicine is transforming CLL treatment. In this episode, discover how precision medicine is used daily in CLL to decide the best managemen ...  Show more

Ep. 241 Chronic Rhinitis: Emerging Approaches & Treatments with Dr. Dennis Tang
BackTable ENT

So many patients deal with a runny, stuffy nose every day, and sprays only go so far. Let’s talk about what’s new for chronic rhinitis. In this episode of the BackTable ENT podcast, Dr. Dennis Tang, a Rhinologist at Cedars-Sinai Medical Center discusses chronic rhinitis and the l ...  Show more

Spotlight on Acute Myeloid Leukemia
Blood Podcast

In this Spotlight series episode on Acute Myeloid Leukemia, Blood Editor, Dr. Selina Luger interviews Drs. Laura Michaelis and Alexander Perl on their paper in the series titled “The fit older adult with acute myeloid leukemia: clinical challenges to providing evidence-based fron ...  Show more

First-line asciminib for chronic myeloid leukemia, a new risk score for clonal cytopenia, and genotyped D-positive blood transfusion in sickle cell anemia
Blood Podcast

In this week's episode we’ll learn more about the ASCEND study, which investigated first-line asciminib in chronic phase chronic myeloid leukemia; a new risk score for myeloid neoplasm transformation in patients with clonal cytopenia of undetermined significance; and use of RHD g ...  Show more